logo-loader
TSX-V:MDX

MedX Health Corp.

Receive alerts
Market:
TSX-V
Price
0.07 CAD
Day Change
-
Market Cap:
$18.34 m
52 weeks high
0.09
52 weeks low
0.03

In brief

MedX Health Corp is a medical device company, with a SaaS (software-as-a-service) recurring revenue model, that's emerging as a global leader in teledermatology. The Canada-based company has developed the SIAscope -- the only image-capture technology on the market that provides clinical, dermoscopic, and spectrophotometric views of moles and lesions up to 2 millimeters (mm) below the skin's surface. MedX's device can capture perfect clinical images with 100% image integrity, which makes it ideal for dermatologists wanting to integrate teledermatology into their practices. 

Snapshot

  • MedX Health plans private placement to raise up to $1.5M through the issuance of one or more secured convertible debentures
  • MedX Health launches two more screening services locations in Ottawa

Insight Widest with the analysis, Proactive gives perspectives that others don't.

MedX Health is expanding North American operations with doctor-pharmacy rollout

The global leader in teledermatology is now offering its life-saving skin-screening services in blended physician and pharmacy clinic settings in Ontario

on 14/2/22